Tag 'Adverse Event Reporting'

Introduction  Brazil has established a comprehensive pharmacovigilance framework designed to ensure the continuous monitoring of the safety and benefit–risk profile of medicinal products throughout their…

Introduction  As pharmaceutical companies continue expanding into global markets, pharmacovigilance (PV) professionals are increasingly required to navigate multiple regulatory frameworks simultaneously. While the European Union’s Good Pharmacovigilance…

The increasing availability of biosimilar medicinal products has transformed healthcare by expanding patient access to life-saving biological therapies while reducing treatment costs. Biosimilars are…

Pharmacovigilance (PV) plays a critical role in ensuring patient safety by monitoring, detecting, assessing, and preventing adverse effects associated with medicinal products. While developed…

Drug safety, is a critical component of the healthcare and pharmaceutical industries. It focuses on detecting, assessing, understanding, and preventing adverse effects or any…

The U.S. Food and Drug Administration announced on March 11, 2026, the launch of a new unified platform for analyzing adverse event reports. The…

The Therapeutic Goods Administration (TGA) of Australia has completed an upgrade of its internal Adverse Event Management System (AEMS) by transitioning the database to a…